Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03616834
Title eFT508 in Combination With PD-1/PD-L1 Inhibitor Therapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Effector Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.